Empagliflozin as a novel therapy for cirrhotic refractory ascites: a randomized controlled study

Abstract Background Cirrhotic refractory ascites (RA) patients have few alternatives for treatment. Empagliflozin is now known to have natriuretic and neurohormonal modulatory effects. This research investigated the safety and efficacy of empagliflozin in the management of RA when added to the stand...

Cijeli opis

Bibliografski detalji

Glavni autori:	Mohamed Fathy Bakosh, Ramy Mohamed Ghazy, Walid Ismail Ellakany, Ahmed Kamal
Format:	Artigo
Jezik:	Inglês
Izdano:	SpringerOpen 2024-10-01
Serija:	Egyptian Liver Journal
Teme:	Ascites Sodium-glucose transporter 2 inhibitors Empagliflozin Diuretics Natriuretic agents
Online pristup:	https://doi.org/10.1186/s43066-024-00383-y
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!